Evidence map›Paper›PMID 42389196›Full record

ArticleClinical kidney journal2026

Dialysis disequilibrium syndrome: an underdiagnosed condition? Results from a monocentric observational study.

Théo Servan-Schreiber, Guillaume Lano, Matthieu Giot, Océane Jehel, Marion Pelletier, Marion Sallée, Philippe Brunet, Stéphane Burtey, Thomas Robert

Abstract read
In one paragraph

Article in Clinical kidney journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Théo Servan-SchreiberCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Guillaume LanoService de Néphrologie, Centre Hospitalier de Bastia, Bastia.
Matthieu GiotCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Océane JehelCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Marion PelletierCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Marion SalléeCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Philippe BrunetCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Stéphane BurteyCentre of Nephrology and Renal Transplantation, Hôpital de la Conception, CHU de Marseille, Marseille, France.
Thomas RobertC2VN, Aix Marseille Univ, INSERM, INRAE, Marseille, France.ORCID https://orcid.org/0000-0002-7580-0913

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Dialysis disequilibrium syndrome (DDS) is a neurological complication occurring during hemodialysis initiation whose pathogenesis remains incompletely understood. Limited prospective adult data exists on DDS incidence and risk factors. Methods: We conducted a prospective observational study (February 2021-February 2022) including 48 patients initiating hemodialysis. DDS was assessed using a standardized severity score (0-3) before and after each of the first four sessions, defined as any increase in post-session score ( Results: Among 48 patients (70.8% male, median age 67 years), 22.9% developed DDS with two patients experiencing multiple episodes. Univariate analysis identified centrally acting agent use (45.5% vs. 8.1%, Conclusion: DDS is a common complication (22.9% incidence) with intradialytic hypertension as the key independent predictor. Pre-dialysis urea concentration was not predictive. These findings suggest a pathophysiological model involving acid-base dynamics and intracranial pressure regulation rather than solute gradients alone. Future multicenter studies are needed to validate these findings and optimize dialysis initiation strategies.

Indexed as

chronic kidney diseasedialysis disequilibrium syndromefluid overloadintradialytic hypertensionmetabolic acidosis

Identifiers

PMID42389196
PMCPMC13320231

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.